The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of actionANDERSEN, P. H.European journal of pharmacology. 1989, Vol 166, Num 3, pp 493-504, issn 0014-2999Article

Comparison of the pharmacological characteristics of [³H]raclopride and [³H]SCH 23390 binding to dopamine receptors in vivo in mouse brainANDERSEN, P. H.European journal of pharmacology. 1988, Vol 146, Num 1, pp 113-120, issn 0014-2999Article

Differential effects of EEDQ on the dopamine D-1 receptor in vivo and in vitroANDERSEN, P. H.European journal of pharmacology. 1988, Vol 152, Num 1-2, pp 153-156, issn 0014-2999Article

Biochemical and pharmacological characterization of [³H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complexANDERSEN, P. H.Journal of neurochemistry. 1987, Vol 48, Num 6, pp 1887-1896, issn 0022-3042Article

Multi-level arc combination with stochastic parametersANDERSEN, P. H.Journal of geodesy (Print). 2000, Vol 74, Num 7-8, pp 531-551, issn 0949-7714Article

Spectral reflectance of human skin in vivoANDERSEN, P. H; BJERRING, P.Photodermatology. 1990, Vol 7, Num 1, pp 5-12, issn 0108-9684, 8 p.Article

Noninvasive computerized analysis of skin chromophores in vivo by reflectance spectroscopyANDERSEN, P. H; BJERRING, P.Photodermatology photoimmunology & photomedicine. 1990, Vol 7, Num 6, pp 249-257Article

Spectral reflectance of human skin in vivoANDERSEN, P. H; BJERRING, P.Photodermatology photoimmunology & photomedicine. 1990, Vol 7, Num 1, pp 5-12, issn 0905-4383Article

Two classes of [³H]spiperone binding sites in bovine neurohypophysis: D-2 receptors and putative 5-HT₂ receptorsTREIMAN, M; ANDERSEN, P. H.Journal of receptor research. 1989, Vol 9, Num 4-5, pp 297-312, issn 0197-5110Article

Skin reflectance spectrophotometryBJERRING, P; ANDERSEN, P. H.Photodermatology. 1987, Vol 4, Num 3, pp 167-171, issn 0108-9684Article

Irradiation inactivation studies of the dopamine D₁ receptor and dopamine-stimulated adenylate cyclase in rat striatumANDERSEN, P. H; NIELSEN, M.Neuroscience letters. 1987, Vol 83, Num 1-2, pp 167-172, issn 0304-3940Article

Lithium inhibition of forskolin-stimulated adenylate cyclaseANDERSEN, P. H; GEISLER, A.Neuropsychobiology. 1984, Vol 12, Num 1, pp 1-3, issn 0302-282XArticle

Effects of heavy metal cations and other sulfhydryl reagents on brain dopamine D1 receptors: evidence for involvement of a thiol group in the conformation of the active siteBRAESTRUP, C; ANDERSEN, P. H.Journal of neurochemistry. 1987, Vol 48, Num 6, pp 1667-1672, issn 0022-3042Article

Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptorANDERSEN, P. H; BRAESTRUP, C.Journal of neurochemistry. 1986, Vol 47, Num 6, pp 1822-1831, issn 0022-3042Article

Mutagenicity of flour from the palmyrah palm (Borassus flabellifer) in Salmonella typhimurium and Escherichia coliANDERSEN, P. H; POULSEN, E.Cancer letters. 1985, Vol 26, Num 1, pp 113-119, issn 0304-3835Article

Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countriesBRANTSAETER, A. B; ROMANUS, V; ANDERSEN, P. H et al.The International journal of tuberculosis and lung disease. 2009, Vol 13, Num 4, pp 440-445, issn 1027-3719, 6 p.Article

Tissue specific distribution of the 3243A→G mtDNA mutationFREDERIKSEN, A. L; ANDERSEN, P. H; KYVIK, K. O et al.Journal of medical genetics. 2006, Vol 43, Num 8, pp 671-677, issn 0022-2593, 7 p.Article

Synthesis and evaluation of cis-1-methyl-3-n-propyl-2,3,3a,4,5,9b-hexahydro-1H-benz[e]indoles for in vitro dopamine D₁ and D₂ receptor binding affinityGHOSH, D; KLEIN, C. L; GARNER, B et al.European journal of medicinal chemistry. 1995, Vol 30, Num 12, pp 943-948, issn 0223-5234Article

Effects of glipizide on glucose metabolism and muscle content of the insulin-regulatable glucose transporter (GLUT 4) and glycogen synthase activity during hyperglycaemia in type 2 diabetic patientsSCHMITZ, O; LUND, S; BAK, J. F et al.Acta diabetologica (Print). 1994, Vol 31, Num 1, pp 31-36, issn 0940-5429Article

Influence of short-term dexfenfluramine therapy on glucose and lipid metabolism in obese non-diabatic patientsANDERSEN, P. H; RICHELSEN, B; BAK, J et al.Acta endocrinologica (Oslo). 1993, Vol 128, Num 3, pp 251-258, issn 0001-5598Article

Identification, characterization, and molecular cloning of a novel transporter-like protein localized to the central nervous systemGINGRICH, J. A; ANDERSEN, P. H; TIBERI, M et al.FEBS letters. 1992, Vol 312, Num 2-3, pp 115-122, issn 0014-5793Article

Chemical and pharmacologic skin irritation in man : a reflectance spectroscopic studyANDERSEN, P. H; NANGIA, A; BJERRING, P et al.Contact dermatitis. 1991, Vol 25, Num 5, pp 283-289, issn 0105-1873Article

A mixed meal potentiates the insulin sensitivity of glucose transport and metabolism in adipocytes from patients with type 2 diabetes mellitusLANGE, A; BAK, J; ANDERSEN, P. H et al.Diabetic medicine. 1988, Vol 5, Num 8, pp 761-765, issn 0742-3071Article

A new series of highly potent growth hormone-releasing peptides derived from ipamorelinANKERSEN, M; JOHANSEN, N. L; LUNDT, B. F et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 19, pp 3699-3704, issn 0022-2623Article

Ipamorelin, the first selective growth hormone secretagogueRAUN, K; HANSEN, B. S; JOHANSEN, N. L et al.European journal of endocrinology. 1998, Vol 139, Num 5, pp 552-561, issn 0804-4643Article